[{"Assets_0_Q3_USD":109042000.0,"CommonStockSharesOutstanding_0_Q3_shares":40844455.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-75520000.0,"NetIncomeLoss_1_Q3_USD":-21949000.0,"NetIncomeLoss_3_Q3_USD":-77655000.0,"StockholdersEquity_0_Q3_USD":-30565000.0,"Ticker":"MCRB","CIK":"1609809","name":"SERES THERAPEUTICS, INC.","OfficialName":"Seres Therapeutics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"533683334.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181108"}]